An additional analysis showed that 28 patients with various non-RA rheumatic diseases, including 12 juvenile idiopathic arthritis, 6 psoriatic arthritis, and 3 ankylosing spondylitis, had been treated with TNF-α-blocking therapy in the study centre. This evidence concerns the gene TNF and ankylosing spondylitis.